UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Polio endgame: the global introduction of inactivated polio vaccine

Expert review of vaccines, 2015-05, Vol.14 (5), p.749-762

2015

Volltextzugriff (PDF)

Economic benefits of keeping vaccines at ambient temperature during mass vaccination: the case of meningitis A vaccine in Chad

Bulletin of the World Health Organization, 2014-02, Vol.92 (2), p.86-92

2014

Volltextzugriff (PDF)

One billion doses and WHO prequalification of nOPV2: Implications for the global polio situation and beyond

PLOS global public health, 2024, Vol.4 (2), p.e0002920-e0002920

2024

Volltextzugriff (PDF)

Novel Oral Polio Vaccine Type 2 Use for Polio Outbreak Response: A Global Effort for a Global Health Emergency

Pathogens (Basel), 2024-04, Vol.13 (4), p.273

2024

Volltextzugriff (PDF)

A novel tool to eradicate an ancient scourge: the novel oral polio vaccine type 2 story

The Lancet infectious diseases, 2023-02, Vol.23 (2), p.e67-e71

2023

Volltextzugriff (PDF)

Vaccine Presentation and Packaging Advisory Group: a forum for reaching consensus on vaccine product attributes

Bulletin of the World Health Organization, 2013-01, Vol.91 (1), p.75-78

2013

Volltextzugriff (PDF)

Knowledge and attitudes towards vaccines and immunization among adolescents in South Africa

Human vaccines, 2010-06, Vol.6 (6), p.455-461

2010

Volltextzugriff (PDF)

Global oral poliovirus vaccine stockpile management as an essential preparedness and response mechanism for type 2 poliovirus outbreaks following global oral poliovirus vaccine type 2 withdrawal

Vaccine, 2023-04, Vol.41 (Suppl 1), p.A70-A78

2023

Volltextzugriff (PDF)

Benefits of using vaccines out of the cold chain: Delivering Meningitis A vaccine in a controlled temperature chain during the mass immunization campaign in Benin

Vaccine, 2014-03, Vol.32 (13), p.1431-1435

2014

Volltextzugriff (PDF)

Enabling accelerated vaccine roll-out for Public Health Emergencies of International Concern (PHEICs): Novel Oral Polio Vaccine type 2 (nOPV2) experience

Vaccine, 2023-04, Vol.41 (Suppl 1), p.A122-A127

2023

Volltextzugriff (PDF)

A Supply and Demand Management Perspective on the Accelerated Global Introductions of Inactivated Poliovirus Vaccine in a Constrained Supply Market

The Journal of infectious diseases, 2017-07, Vol.216 (suppl_1), p.S33-S39

2017

Volltextzugriff (PDF)

nOPV2 development as a global effort for polio outbreak response

The Lancet global health, 2023-11, Vol.11 (11), p.e1695-e1695

2023

Volltextzugriff (PDF)

Effectiveness of poliovirus vaccines against circulating vaccine-derived type 2 poliomyelitis in Nigeria between 2017 and 2022: a case-control study

The Lancet infectious diseases, 2024-04, Vol.24 (4), p.427-436

2024

Volltextzugriff (PDF)

Lessons Learned From Managing the Planning and Implementation of Inactivated Polio Vaccine Introduction in Support of the Polio Endgame

The Journal of infectious diseases, 2017-07, Vol.216 (suppl_1), p.S15-S23

2017

Volltextzugriff (PDF)

Polio Endgame: Lessons Learned From the Immunization Systems Management Group

The Journal of infectious diseases, 2017-07, Vol.216 (suppl_1), p.S9-S14

2017

Volltextzugriff (PDF)

Financial Support to Eligible Countries for the Switch From Trivalent to Bivalent Oral Polio Vaccine—Lessons Learned

The Journal of infectious diseases, 2017-07, Vol.216 (suppl_1), p.S57-S65

2017

Volltextzugriff (PDF)

A cluster randomized non-inferiority field trial on the immunogenicity and safety of tetanus toxoid vaccine kept in controlled temperature chain compared to cold chain

Vaccine, 2014-10, Vol.32 (47), p.6220-6226

2014

Volltextzugriff (PDF)

Economic benefits of keeping vaccines at ambient temperature during mass vaccination: the case of meningitis A vaccine in Chad/Avantages economiques de la conservation des vaccins a temperature ambiante pendant les campagnes de vaccination de masse: le cas du vaccin contre la meningite A au Tchad

Bulletin of the World Health Organization, 2014-02, Vol.92 (2), p.86

2014

Volltextzugriff (PDF)

Assessing the potency of oral polio vaccine kept outside of the cold chain during a national immunization campaign in Chad

Vaccine, 2011-08, Vol.29 (34), p.5652-5656

2011

Volltextzugriff (PDF)

Vaccine Presentation and Packaging Advisory Group: a forum for reaching consensus on vaccine product attributes

Bulletin of the World Health Organization, 2013-01, Vol.91 (1), p.75-78

2013

Volltextzugriff (PDF)

Using oral polio vaccine beyond the cold chain: A feasibility study conducted during the national immunization campaign in Mali

Vaccine, 2010-04, Vol.28 (19), p.3467-3472

2010

Volltextzugriff (PDF)

Genetic Characterization of Novel Oral Polio Vaccine Type 2 Viruses During Initial Use Phase Under Emergency Use Listing - Worldwide, March-October 2021

MMWR. Morbidity and mortality weekly report, 2022-06, Vol.71 (24), p.786-790

2022

Volltextzugriff (PDF)

Notes from the Field : Circulating Vaccine-Derived Poliovirus Type 2 Emergences Linked to Novel Oral Poliovirus Vaccine Type 2 Use — Six African Countries, 2021–2023

MMWR. Morbidity and mortality weekly report, 2023-09, Vol.72 (38), p.1041-1042

2023

Volltextzugriff (PDF)

Circulating Vaccine-Derived Poliovirus Type 2 Emergences Linked to Novel Oral Poliovirus Vaccine Type 2 Use--Six African Countries, 2021-2023

Morbidity and Mortality Weekly Report, 2023, Vol.72 (38), p.1041

2023

Volltextzugriff (PDF)

Genetic characterization of novel oral polio vaccine type 2 viruses during initial use phase under emergency use listing--worldwide, March-October 2021/Caracterisation genetique des virus issus du nouveau vaccin antipoliomyelitique oral de type 2 pendant la phase initiale d'utilisation d'urgence au titre du protocole EUL--dans le monde, mars-octobre 2021

Weekly epidemiological record, 2022-07, Vol.97 (26), p.303

2022

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(25)
Newsletter-Artikel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Vaccines
(18)
Humans
(17)
Life Sciences & Biomedicine
(17)
Science & Technology
(17)
Poliomyelitis - Prevention & Control
(13)
Immunization
(10)
Immunology
(10)
Poliomyelitis
(10)
Microbiology
(9)
Global Health
(8)
Infectious Diseases
(8)
Biological And Medical Sciences
(6)
Oral Polio Vaccine
(6)
Poliomyelitis - Epidemiology
(6)
Poliovirus
(6)
Viruses
(6)
Cold
(5)
Outbreaks
(5)
Polio
(5)
Poliovirus Vaccine, Oral
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Polio endgame: the global introduction of inactivated polio vaccine

Economic benefits of keeping vaccines at ambient temperature during mass vaccination: the case of meningitis A vaccine in Chad

One billion doses and WHO prequalification of nOPV2: Implications for the global polio situation and beyond

Novel Oral Polio Vaccine Type 2 Use for Polio Outbreak Response: A Global Effort for a Global Health Emergency

A novel tool to eradicate an ancient scourge: the novel oral polio vaccine type 2 story

Vaccine Presentation and Packaging Advisory Group: a forum for reaching consensus on vaccine product attributes

Knowledge and attitudes towards vaccines and immunization among adolescents in South Africa

Global oral poliovirus vaccine stockpile management as an essential preparedness and response mechanism for type 2 poliovirus outbreaks following global oral poliovirus vaccine type 2 withdrawal

Benefits of using vaccines out of the cold chain: Delivering Meningitis A vaccine in a controlled temperature chain during the mass immunization campaign in Benin

Enabling accelerated vaccine roll-out for Public Health Emergencies of International Concern (PHEICs): Novel Oral Polio Vaccine type 2 (nOPV2) experience

A Supply and Demand Management Perspective on the Accelerated Global Introductions of Inactivated Poliovirus Vaccine in a Constrained Supply Market

nOPV2 development as a global effort for polio outbreak response

Effectiveness of poliovirus vaccines against circulating vaccine-derived type 2 poliomyelitis in Nigeria between 2017 and 2022: a case-control study

Lessons Learned From Managing the Planning and Implementation of Inactivated Polio Vaccine Introduction in Support of the Polio Endgame

Polio Endgame: Lessons Learned From the Immunization Systems Management Group

Financial Support to Eligible Countries for the Switch From Trivalent to Bivalent Oral Polio Vaccine—Lessons Learned

A cluster randomized non-inferiority field trial on the immunogenicity and safety of tetanus toxoid vaccine kept in controlled temperature chain compared to cold chain

Economic benefits of keeping vaccines at ambient temperature during mass vaccination: the case of meningitis A vaccine in Chad/Avantages economiques de la conservation des vaccins a temperature ambiante pendant les campagnes de vaccination de masse: le cas du vaccin contre la meningite A au Tchad

Assessing the potency of oral polio vaccine kept outside of the cold chain during a national immunization campaign in Chad

Vaccine Presentation and Packaging Advisory Group: a forum for reaching consensus on vaccine product attributes

Using oral polio vaccine beyond the cold chain: A feasibility study conducted during the national immunization campaign in Mali

Genetic Characterization of Novel Oral Polio Vaccine Type 2 Viruses During Initial Use Phase Under Emergency Use Listing - Worldwide, March-October 2021

Notes from the Field : Circulating Vaccine-Derived Poliovirus Type 2 Emergences Linked to Novel Oral Poliovirus Vaccine Type 2 Use — Six African Countries, 2021–2023

Circulating Vaccine-Derived Poliovirus Type 2 Emergences Linked to Novel Oral Poliovirus Vaccine Type 2 Use--Six African Countries, 2021-2023

Suchergebnisse filtern